TABLE 2.
Experimental conditions | γ | Po | τopen | N;n |
---|---|---|---|---|
pS | ms | |||
PM | 107 ± 6 | 0.020 ± 0.002 | 1.2 ± 0.2 | 32,796; 10 |
PM + iminodibenzyl | 65 ± 5 | 0.010 ± 0.003 | 1.6 ± 0.3 | 6,187; 5 |
PM E40A | 78 ± 8 | 0.07 ± 0.04 | 1.8 ± 0.4 | 31,160; 7 |
PM E40C | 80 ± 7 | 0.06 ± 0.03 | 1.1 ± 0.3 | 14,295; 5 |
PM E40A + imipramine | 76 ± 7 | 0.11 ± 0.05 | 2.3 ± 0.5 | 60,856; 5 |
PM E40A + CTX | 75 ± 8 | 0.11 ± 0.04 | 3.1 ± 0.6 | 19,597; 5 |
PM E40C-fluorescein | 7 ± 1 | 0.74 ± 0.05 | 120 ± 30 | 5,400; 4 |